EBIT: Income before interest and taxes.
Tevogen Bio Holdings Inc. (TVGN) had EBIT of $-5.40M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-5.62M |
|
-- |
|
-- |
|
$5.40M |
|
$-5.40M |
|
$-0.05M |
|
$-5.45M |
|
$-5.45M |
|
$-5.45M |
|
$-5.45M |
|
$-5.45M |
|
$-5.45M |
|
|
EBIT |
$-5.40M |
$-5.34M |
|
3.49M |
|
3.49M |
|
$-1.61 |
|
$-1.61 |
|
| Balance Sheet Financials | |
$2.14M |
|
$0.14M |
|
$2.78M |
|
$4.92M |
|
$7.27M |
|
$6.40M |
|
$7.49M |
|
$14.76M |
|
$-18.64M |
|
$-9.84M |
|
$-9.84M |
|
4.17M |
|
| Cash Flow Statement Financials | |
$-2.73M |
|
-- |
|
$2.87M |
|
$0.55M |
|
$0.69M |
|
$0.14M |
|
$2.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.29 |
|
-- |
|
-- |
|
-1.86 |
|
-0.82 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
29.21% |
|
55.34% |
|
-110.67% |
|
158.22% |
|
$-2.36 |
|
$-0.78 |
|
$-0.78 |
|